31 articles for D Steinhilber
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
49
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor¿ Modulators.
Goethe-University Frankfurt
30
Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism.
Goethe-University Frankfurt
49
Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.
Goethe-University Frankfurt
38
Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist.
Goethe-University Frankfurt
12
Exploring the chemical space of multitarget ligands using aligned self-organizing maps.
Goethe University
26
Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase.
Goethe-University Frankfurt
21
Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors.
Zafes/Liff/Osf Goethe-University Frankfurt
9
Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering.
TBA
36
Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
Zafes/Liff/Osf Goethe-University Frankfurt
36
A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
Goethe-University Frankfurt
33
SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
Zafes/Liff/Osf Goethe-University Frankfurt
3
Bioactivity-guided mapping and navigation of chemical space.
Institut FüR Molekulare Physiologie
12
Identification of a Chemical Probe for BLT2 Activation by Scaffold Hopping.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
2
Development of a Potent and Selective G2A (GPR132) Agonist.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
20
Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.
Johann Wolfgang Goethe-UniversitäT
2
Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.
Johann Wolfgang Goethe University
5
Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.
Johann Wolfgang Goethe-UniversitäT
52
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors.
Goethe-University
14
Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening.
Fraunhofer Institute For Translational Medicine and Phamacology Itmp
44
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase.
Goethe-University of Frankfurt
41
First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters.
Fraunhofer Ime
7
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ.
Goethe-University Frankfurt
5
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
Goethe-University Frankfurt
27
Structure optimization of a new class of PPARγ antagonists.
Fraunhofer Institute For Molecular Biology and Applied Ecology Ime
17
Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA
Goethe University Frankfurt
2
Computer-Aided Selective Optimization of Side Activities of Talinolol.
Goethe-University of Frankfurt
10
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology.
Goethe University Frankfurt
46
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis.
Goethe-University Frankfurt
